References
- Quadrelli S, Dubinsky D, Solis M, et al. Immune diffuse alveolar hemorrhage: clinical presentation and outcome. Respir Med. 2017;129:59–62.
- Nasser M, Cottin V. Alveolar hemorrhage in vasculitis (primary and secondary) semin respir. Semin Respir Crit Care Med. 2018;39:482–493.
- Naniwa T, Banno S, Sugiura Y, et al. Pulmonary-renal syndrome in systemic sclerosis: a report of three cases and review of the literature. Mod Rheumatol. 2007;17(1):37–44.
- Bukamur H, Aqtash O, Shahoub I, et al. Atypical rapid onset Scleroderma Renal Crisis (SRC) complicated with diffuse alveolar hemorrhage and pleuro-pericardial effusions in a patient with recently diagnosed breast cancer and a positive anti-RNA polymerase III Ab.: a case report. Respir Med Case Rep. 2018;25:137–141.
- Miyazaki S, Ikeda T, Ito G, et al. Pulmonary tumor thrombotic microangiopathy successfully treated with corticosteroids: a case report. J Med Case Rep. 2017;11(1):356.
- Toyoshima M, Chida K, Enomoto N, et al. A case of diffuse alveolar hemorrhage associated with interstitial pneumonia and systemic sclerosis. Ann Jpn Respir Soc. 2005;43:437–440.
- Chaer RA, Massad MG, Evans A, et al. Systemic sclerosis complicated by diffuse alveolar hemorrhage. Med Sci Monit. 2001;7(5):1013–1015.
- Rodnan GP, Lipinski E, Luksick J. Skin thickness and collagen content in progressive systemic sclerosis (scleroderma) and localized scleroderma. Arthritis Rheum. 1979;22(2):130–140.
- LeRoy EC, Medsger TA. Jr. Criteria for the classification of early systemic sclerosis. J Rheumatol. 2001;28(7):1573–1576.
- Ghrénassia E, Avouac J, Khanna D, et al. Prevalence, correlates and outcomes of gastric antral vascular ectasia in systemic sclerosis: a EUSTAR case-control study. J Rheumatol. 2014;41(1):99–105.
- Hoffmann-Vold AM, Midtvedt Ø, Tennøe AH, et al. Cardiopulmonary disease development in anti-RNA polymerase III-positive systemic sclerosis: comparative analyses from an unselected, prospective patient cohort. J Rheumatol. 2017;44(4):459–465.
- Hamaguchi Y, Kodera M, Matsushita T, et al. Clinical and immunologic predictors of scleroderma renal crisis in Japanese systemic sclerosis patients with anti–RNA polymerase III autoantibodies. Arthritis Rheum. 2015;67(4):1045–1052.
- Igusa T, Hummers LK, Visvanathan K, et al. Autoantibodies and scleroderma phenotype define subgroups at high-risk and low-risk for cancer. Ann Rheum Dis. 2018;77(8):1179–1186.